323 filings
8-K
EXEL
Exelixis Inc
3 Jun 24
Departure of Directors or Certain Officers
5:21pm
8-K
EXEL
Exelixis Inc
20 May 24
Other Events
4:41pm
8-K
EXEL
Exelixis Inc
10 May 24
Other Events
4:05pm
8-K
EXEL
Exelixis Inc
30 Apr 24
Exelixis Announces First Quarter 2024 Financial Results and Provides Corporate Update
4:12pm
8-K
EXEL
Exelixis Inc
29 Mar 24
Departure of Directors or Certain Officers
4:14pm
8-K
uxvn gbil2y7u5j
6 Feb 24
Exelixis Announces Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Corporate Update
4:28pm
8-K
fdnyg0f2w
8 Jan 24
Results of Operations and Financial Condition
9:06am
8-K
hxj0i4n j2
20 Dec 23
Departure of Directors or Certain Officers
4:20pm
8-K
ipp 65r0mq
1 Nov 23
Exelixis Announces Third Quarter 2023 Financial Results and Provides Corporate Update
4:08pm
8-K
ou2e0yspuqebs
19 Sep 23
Departure of Directors or Certain Officers
4:20pm
8-K
s0fb190ogztoabry
23 Aug 23
Departure of Directors or Certain Officers
4:37pm
8-K
az6snjyl8bse zk
1 Aug 23
Exelixis Announces Second Quarter 2023 Financial Results and Provides Corporate Update
4:11pm
8-K
z3tu0onvti7 9rj3px
24 Jul 23
Other Events
4:41pm
8-K
gbwnq
5 Jun 23
Submission of Matters to a Vote of Security Holders
4:35pm
8-K
jsym1 pjh6r
9 May 23
Exelixis Announces First Quarter 2023 Financial Results and Provides Corporate Update
4:13pm
8-K
v346pa4b
8 May 23
Exelixis Announces Departure of Lance Willsey, M.D. from Board of Directors
6:13am
8-K
nkvlzmgnh85
13 Apr 23
Departure of Directors or Certain Officers
4:26pm
8-K
m2vbwdpmm
22 Mar 23
Other Events
4:36pm
8-K
wr177 w1eopa9fyh
20 Mar 23
Exelixis Announces $550 Million Share Repurchase Program
7:04am
8-K
2s0yoh8d ok
7 Feb 23
Exelixis Announces Fourth Quarter and Full Year 2022 Financial Results
4:09pm